Variant report

Variant	esv1833664
Chromosome Location	chr4:100495571-100504985
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:72)
CpG islands
(count:61)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:72 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:100495701-100496496	HepG2	liver:	n/a	n/a
2	CEBPB	chr4:100495821-100496047	HepG2	liver:	n/a	n/a
3	CUX1	chr4:100496835-100497034	GM12878	blood:	n/a	n/a
4	E2F4	chr4:100495774-100495957	MCF10A-Er-Src	breast:	n/a	n/a
5	EP300	chr4:100495667-100496229	HepG2	liver:	n/a	n/a
6	EP300	chr4:100495693-100496094	HepG2	liver:	n/a	n/a
7	EP300	chr4:100495855-100496158	HepG2	liver:	n/a	n/a
8	EP300	chr4:100498174-100498189	GM12878	blood:	n/a	n/a
9	EP300	chr4:100495815-100496501	GM12878	blood:	n/a	n/a
10	EP300	chr4:100498111-100498127	GM12878	blood:	n/a	n/a
11	FOXA1	chr4:100495796-100496206	HepG2	liver:	n/a	n/a
12	FOXA1	chr4:100495676-100496242	HepG2	liver:	n/a	n/a
13	FOXA1	chr4:100495662-100496202	HepG2	liver:	n/a	n/a
14	FOXA1	chr4:100495665-100496171	HepG2	liver:	n/a	n/a
15	FOXA2	chr4:100495563-100496461	HepG2	liver:	n/a	n/a
16	FOXA2	chr4:100495728-100496173	HepG2	liver:	n/a	n/a
17	HDAC2	chr4:100495705-100496198	HepG2	liver:	n/a	n/a
18	HDAC2	chr4:100495709-100496105	HepG2	liver:	n/a	n/a
19	HEY1	chr4:100495684-100496359	HepG2	liver:	n/a	n/a
20	HEY1	chr4:100495848-100496220	HepG2	liver:	n/a	n/a
21	HNF4A	chr4:100495731-100496217	HepG2	liver:	n/a	chr4:100495926-100495948 chr4:100495931-100495943 chr4:100495898-100495911 chr4:100495898-100495911
22	HNF4A	chr4:100495749-100496133	HepG2	liver:	n/a	chr4:100495926-100495948 chr4:100495931-100495943 chr4:100495898-100495911 chr4:100495898-100495911
23	HNF4A	chr4:100495699-100496153	HepG2	liver:	n/a	chr4:100495926-100495948 chr4:100495931-100495943 chr4:100495898-100495911 chr4:100495898-100495911
24	HNF4G	chr4:100495746-100496149	HepG2	liver:	n/a	chr4:100495926-100495948 chr4:100495931-100495943 chr4:100495898-100495911 chr4:100495898-100495911
25	HNF4G	chr4:100495675-100496262	HepG2	liver:	n/a	chr4:100495926-100495948 chr4:100495931-100495943 chr4:100495898-100495911 chr4:100495898-100495911
26	MAFK	chr4:100497353-100497456	HepG2	liver:	n/a	n/a
27	MAZ	chr4:100495785-100496130	HepG2	liver:	n/a	n/a
28	MBD4	chr4:100495703-100496349	HepG2	liver:	n/a	n/a
29	MXI1	chr4:100495832-100496222	HepG2	liver:	n/a	n/a
30	MYBL2	chr4:100495474-100496594	HepG2	liver:	n/a	n/a
31	MYBL2	chr4:100495687-100496289	HepG2	liver:	n/a	n/a
32	MYC	chr4:100495975-100495982	HepG2	liver:	n/a	n/a
33	NFIC	chr4:100495659-100496373	HepG2	liver:	n/a	n/a
34	NFIC	chr4:100495688-100496214	HepG2	liver:	n/a	n/a
35	NR2F2	chr4:100495592-100496362	HepG2	liver:	n/a	n/a
36	NR2F2	chr4:100495716-100496297	HepG2	liver:	n/a	n/a
37	POLR2A	chr4:100495806-100496304	HepG2	liver:	n/a	n/a
38	POLR2A	chr4:100495862-100496145	HepG2	liver:	n/a	n/a
39	POLR2A	chr4:100495759-100496300	HepG2	liver:	n/a	n/a
40	POLR2A	chr4:100495837-100496207	HepG2	liver:	n/a	n/a
41	POLR2A	chr4:100495895-100496114	HepG2	liver:	n/a	n/a
42	POLR2A	chr4:100495836-100496224	HepG2	liver:	n/a	n/a
43	POLR2A	chr4:100502545-100502601	MCF10A-Er-Src	breast:	n/a	n/a
44	POLR2A	chr4:100496147-100496194	H1-hESC	embryonic stem cell:	n/a	n/a
45	RAD21	chr4:100495819-100496121	HepG2	liver:	n/a	n/a
46	RCOR1	chr4:100495889-100496219	HepG2	liver:	n/a	n/a
47	REST	chr4:100495763-100496250	HepG2	liver:	n/a	n/a
48	REST	chr4:100496245-100496443	Hela-S3	cervix:	n/a	n/a
49	RXRA	chr4:100495738-100496111	HepG2	liver:	n/a	chr4:100495931-100495945
50	SIN3AK20	chr4:100495787-100496211	HepG2	liver:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:100495869-100495919	AoSMC	blood vessel:	n/a
2	chr4:100495869-100495919	SK-N-MC	brain:	n/a
3	chr4:100495869-100495919	BJ	skin:	n/a
4	chr4:100495869-100495919	HNPCEpiC	eye:	n/a
5	chr4:100495869-100495919	GM19239	blood:	n/a
6	chr4:100495869-100495919	IMR90	lung:	fetal
7	chr4:100495869-100495919	NHBE	bronchial:	n/a
8	chr4:100495869-100495919	HEK293	kidney:	embryo
9	chr4:100495869-100495919	U87	brain:	n/a
10	chr4:100495869-100495919	HIPEpiC	eye:	n/a
11	chr4:100495869-100495919	PrEC	prostate:	n/a
12	chr4:100495869-100495919	ProgFib	skin:	n/a
13	chr4:100495869-100495919	AG04450	lung:	fetal
14	chr4:100495869-100495919	GM06990	blood:	n/a
15	chr4:100495869-100495919	SK-N-SH_RA	brain:	n/a
16	chr4:100495869-100495919	CMK	blood:	n/a
17	chr4:100495869-100495919	Caco-2	colon:	n/a
18	chr4:100495869-100495919	ovcar-3	ovarian:	n/a
19	chr4:100495869-100495919	NB4	blood:	n/a
20	chr4:100495869-100495919	HPAEpiC	pulmonary alveolar:	n/a
21	chr4:100495869-100495919	AG04449	skin:	fetal
22	chr4:100495869-100495919	HRCEpiC	kidney:	n/a
23	chr4:100495869-100495919	MCF10A-Er-Src	breast:	n/a
24	chr4:100495869-100495919	Jurkat	blood:	n/a
25	chr4:100495869-100495919	RPTEC	kidney:	n/a
26	chr4:100495869-100495919	SAEC	small airway:	n/a
27	chr4:100495869-100495919	HCM	heart:	n/a
28	chr4:100495869-100495919	NHDF-neo	bronchial:	n/a
29	chr4:100495869-100495919	K562	blood:	n/a
30	chr4:100495869-100495919	PANC-1	pancreas:	n/a
31	chr4:100495869-100495919	GM12891	blood:	n/a
32	chr4:100495869-100495919	AG10803	skin:	n/a
33	chr4:100495869-100495919	Hepatocyte	liver:	n/a
34	chr4:100495869-100495919	HRPEpiC	eye:	n/a
35	chr4:100495869-100495919	AG09309	skin:	n/a
36	chr4:100495869-100495919	HMEC	breast:	n/a
37	chr4:100495869-100495919	HRE	kidney:	n/a
38	chr4:100495869-100495919	PFSK-1	brain:	n/a
39	chr4:100495869-100495919	HL-60	blood:	n/a
40	chr4:100495869-100495919	H1-hESC	embryonic stem cell:	embryo
41	chr4:100495869-100495919	BE2_C	brain:	n/a
42	chr4:100495869-100495919	HAEpiC	amniotic membrane:	n/a
43	chr4:100495869-100495919	HepG2	liver:	n/a
44	chr4:100495869-100495919	HEEpiC	esophagus:	n/a
45	chr4:100495869-100495919	HCPEpiC	choroid plexus:	n/a
46	chr4:100495869-100495919	GM12878	blood:	n/a
47	chr4:100495869-100495919	T-47D	breast:	n/a
48	chr4:100495869-100495919	HCT-116	colon:	n/a
49	chr4:100495869-100495919	SK-N-SH	brain:	n/a
50	chr4:100495869-100495919	LNCaP	prostate:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:100483045..100486564-chr4:100504350..100510327,11	MCF-7	breast:
2	chr4:100483825..100487771-chr4:100493784..100496037,3	K562	blood:
3	chr4:100496472..100498863-chr4:100499241..100501789,2	K562	blood:
4	chr4:100493820..100495717-chr4:100499196..100502149,2	K562	blood:
5	chr4:100496472..100498863-chr4:100499241..100501789,2	K562	blood:
6	chr4:100493820..100495717-chr4:100499196..100502149,2	K562	blood:
7	chr4:100491991..100494420-chr4:100498993..100500617,2	MCF-7	breast:
8	chr4:100483825..100487294-chr4:100492777..100496037,4	K562	blood:
9	chr4:100502584..100505204-chr4:100505881..100508949,3	K562	blood:

No data

Variant related genes	Relation type
MTTP	TF binding region
MTTP	CpG island
ENSG00000145331	chromatin interactions
ENSG00000138823	chromatin interactions

Extended variants
information (count: 293 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:293 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6532821	chr4:100495571-100495572	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs1800803	chr4:100495581-100495582	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs144053138	chr4:100495593-100495594	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs574807490	chr4:100495729-100495730	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs542232584	chr4:100495748-100495749	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs560479344	chr4:100495752-100495753	Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs1800804	chr4:100495817-100495818	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs573024574	chr4:100495830-100495831	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs540572452	chr4:100495865-100495866	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs565172986	chr4:100495869-100495870	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs189548141	chr4:100495883-100495884	Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs145929301	chr4:100495988-100495989	Enhancers Flanking Active TSS Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs113822122	chr4:100496007-100496008	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs181769817	chr4:100496013-100496014	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs184382113	chr4:100496046-100496047	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs41275707	chr4:100496061-100496062	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs372447205	chr4:100496073-100496074	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs7667001	chr4:100496105-100496106	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs371979566	chr4:100496109-100496110	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs573682440	chr4:100496119-100496120	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs375134635	chr4:100496151-100496152	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs371904101	chr4:100496192-100496193	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs552480701	chr4:100496196-100496197	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs371084622	chr4:100496208-100496209	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs370188861	chr4:100496243-100496244	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs3833621	chr4:100496262-100496263	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs538451791	chr4:100496264-100496265	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs556455485	chr4:100496295-100496296	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs574881130	chr4:100496302-100496303	Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs535540658	chr4:100496450-100496451	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs573365060	chr4:100496478-100496479	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs189624112	chr4:100496504-100496505	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs546194629	chr4:100496547-100496548	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs565211952	chr4:100496603-100496604	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs577029668	chr4:100496649-100496650	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs544415897	chr4:100496706-100496707	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs544799918	chr4:100496873-100496874	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs17598226	chr4:100496891-100496892	Enhancers Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs529891383	chr4:100496903-100496904	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs368009847	chr4:100496931-100496932	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs559794330	chr4:100496982-100496983	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs11937273	chr4:100497063-100497064	Active TSS Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs180848705	chr4:100497148-100497149	Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs28666735	chr4:100497187-100497188	Active TSS Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs531865224	chr4:100497305-100497306	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs540408316	chr4:100497319-100497320	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs565471790	chr4:100497342-100497343	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs560857216	chr4:100497351-100497352	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs186689918	chr4:100497445-100497446	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs568599402	chr4:100497448-100497449	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	16573809	CNVD
Multiple myeloma	16616336	CNVD
Melanoma	20688739	CNVD
Gastric cancer	16891809	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Bipolar disorder	19114987	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:110 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:100493800-100495800	Enhancers	Cortex derived primary cultured neurospheres	brain
2	chr4:100494200-100495800	Weak transcription	Skeletal Muscle Female	skeletal muscle
3	chr4:100494400-100495800	Weak transcription	Aorta	Aorta
4	chr4:100494600-100495600	Enhancers	Fetal Intestine Large	intestine
5	chr4:100494600-100495800	Enhancers	Fetal Intestine Small	intestine
6	chr4:100495000-100495600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
7	chr4:100495000-100495800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr4:100495000-100495800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr4:100495000-100496400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr4:100495200-100495800	Enhancers	iPS-18 Cell Line	embryonic stem cell
11	chr4:100495200-100495800	Weak transcription	Ovary	ovary
12	chr4:100495200-100495800	Weak transcription	Rectal Smooth Muscle	rectum
13	chr4:100495200-100496000	Weak transcription	Duodenum Smooth Muscle	Duodenum
14	chr4:100495200-100496000	Flanking Active TSS	HepG2	liver
15	chr4:100495400-100495600	Active TSS	Duodenum Mucosa	Duodenum
16	chr4:100495400-100496200	Flanking Active TSS	Liver	Liver
17	chr4:100495400-100497000	Enhancers	HUES64 Cell Line	embryonic stem cell
18	chr4:100495600-100495800	Flanking Active TSS	Duodenum Mucosa	Duodenum
19	chr4:100495600-100495800	Active TSS	Stomach Smooth Muscle	stomach
20	chr4:100495600-100495800	Enhancers	GM12878-XiMat	blood
21	chr4:100495600-100496000	Enhancers	HUES48 Cell Line	embryonic stem cell
22	chr4:100495600-100496000	Enhancers	iPS-20b Cell Line	embryonic stem cell
23	chr4:100495600-100497000	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr4:100495600-100497200	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr4:100495600-100500400	Active TSS	Fetal Intestine Large	intestine
26	chr4:100495800-100496000	Enhancers	ES-I3 Cell Line	embryonic stem cell
27	chr4:100495800-100496000	Enhancers	Skeletal Muscle Female	skeletal muscle
28	chr4:100495800-100496200	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr4:100495800-100496200	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
30	chr4:100495800-100496200	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
31	chr4:100495800-100496200	Enhancers	Colon Smooth Muscle	Colon
32	chr4:100495800-100496200	Active TSS	Rectal Smooth Muscle	rectum
33	chr4:100495800-100496200	Enhancers	Stomach Mucosa	stomach
34	chr4:100495800-100496400	Enhancers	H1 Cell Line	embryonic stem cell
35	chr4:100495800-100496400	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr4:100495800-100496400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
37	chr4:100495800-100496400	Enhancers	Primary monocytes fromperipheralblood	blood
38	chr4:100495800-100496400	Enhancers	Primary B cells from cord blood	blood
39	chr4:100495800-100496400	Active TSS	Brain Anterior Caudate	brain
40	chr4:100495800-100496400	Flanking Active TSS	Stomach Smooth Muscle	stomach
41	chr4:100495800-100496600	Enhancers	Primary B cells from peripheral blood	blood
42	chr4:100495800-100496600	Active TSS	Aorta	Aorta
43	chr4:100495800-100496600	Active TSS	Ovary	ovary
44	chr4:100495800-100496600	Flanking Active TSS	GM12878-XiMat	blood
45	chr4:100495800-100500400	Active TSS	Fetal Intestine Small	intestine
46	chr4:100495800-100500800	Active TSS	Duodenum Mucosa	Duodenum
47	chr4:100496000-100496200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr4:100496000-100496400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
49	chr4:100496000-100496400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
50	chr4:100496000-100496400	Active TSS	Brain Substantia Nigra	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links